Tam-Bran Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Indore, Madhya Pradesh, India, established in 1994.
1994 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Tam-Bran Pharmaceuticals Private Limited

Tam-Bran Pharmaceuticals Private Limited, a active private limited company, was established on 30 September 1994 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U02423MP1994PTC008677. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹10.38 Cr.

Formerly known as Tam-Bran Pharmaceuticals Limited. It upholds a compliant status. Employing 19 professional, Its leadership includes Deependra Kumar Tamotia (Managing Director), Aditya Kumar Tamotia (Director), Abha Rani Tamotia (Director). Past directors included Raj Kumar Tamotia, Priya Shukla, Dhruvi Tamotia. It holds ₹49.84 Cr open charges and ₹14.29 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No-303, Diamond Trade Centre Janjeerwala Square, Indore, Madhya Pradesh, 452003.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U02423MP1994PTC008677

  • Registration Number

    008677

  • Incorporation Date

    30 September 1994

  • Authorized Capital

    ₹15.00 Cr

  • Paid-Up Capital

    ₹10.38 Cr

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 15.00 Cr
  • Paid Up Capital ₹ 10.38 Cr
  • Company Age 31 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 49.84 Cr
  • Satisfied Charges ₹ 14.29 Cr
  • Revenue Growth **** 64.67%
  • Profit Growth **** 510.63%
  • Ebitda **** -20.43%
  • Net Worth 2.35%
  • Total Assets **** 3.87%
Company report

Tam-Bran Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Tam-Bran Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Tam-Bran Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Deependra Kumar Tamotia Managing Director 30 Sep 1994 Current
Aditya Kumar Tamotia Director 17 Sep 2011 Current
Abha Rani Tamotia Director 21 Apr 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 27 Jun 2014 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Director 12 May 2022 Past
Pramod Abcsdd Director 30 May 2017 Past
Pramod Abcsdd Director 27 Jun 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Tam-Bran Pharmaceuticals.

Tam-Bran Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 64.67% increase. The company also saw a substantial improvement in profitability, with a 510.63% increase in profit. The company's net worth moved up by a moderate rise of 2.35%.

Tam-Bran Pharmaceuticals revenue growth over time
Tam-Bran Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 64.67%
*******
*******
*******
*******
Revenue from Operations
*******
 64.43%
*******
*******
*******
*******
Total Assets
*******
 3.87%
*******
*******
*******
*******
Profit or Loss
*******
 510.63%
*******
*******
*******
*******
Net Worth
*******
 2.35%
*******
*******
*******
*******
EBITDA
*******
 -20.43%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Tam-Bran Pharmaceuticals?

In 2023, Tam-Bran Pharmaceuticals had a promoter holding of 12.95% and a public holding of 87.05%. The company had 3 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹498,381,839.00

Satisfied Charges

₹142,880,903.00

Charges Breakdown by Lending Institutions
  • Others : 47.90 Cr
  • Hdfc Bank Limited : 1.94 Cr
Latest Charge Details
Date Lender Amount Status
25 Mar 2025 Hdfc Bank Limited ₹2.31 M Open
10 Feb 2025 Hdfc Bank Limited ₹3.65 M Open
29 Jun 2024 Others ₹28.80 Cr Open
23 Feb 2024 Hdfc Bank Limited ₹1.34 Cr Open
19 Jul 2023 Others ₹17.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Tam-Bran Pharmaceuticals?

Tam-Bran Pharmaceuticals has a workforce of 19 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Tam-Bran Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tam-Bran Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Tam-Bran Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Muskan Jain was appointed as a Company Secretary was appointed as a Company Secretary on 04 Aug 2025 & has been associated with this company since 10 months 3 days . was documented.

  • Director Appointment

    Abha Rani Tamotia was appointed as a Director was appointed as a Director on 21 Apr 2025 & has been associated with this company since 1 year 1 month . was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.23 Cr with Charge ID 101073624 was registered on 25 Mar 2025. was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.37 Cr with Charge ID 101071202 was registered on 10 Feb 2025. was recorded as a recent event.

  • Director Appointment

    Cherry Jain was appointed as a Company Secretary was appointed as a Company Secretary on 28 Dec 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.

  • Charges

    Progress on A charge registered on 26 Apr 2019 via Charge ID 100257718 with Others was fully satisfied on 28 Nov 2024. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Tam-Bran Pharmaceuticals Private Limited?

The CIN of Tam-Bran Pharmaceuticals Private Limited is U02423MP1994PTC008677.

Where is Tam-Bran Pharmaceuticals Private Limited headquartered?

Tam-Bran Pharmaceuticals Private Limited is headquartered at Office No-303, Diamond Trade Centre Janjeerwala Square, Indore, Madhya Pradesh, 452003.

When was Tam-Bran Pharmaceuticals Private Limited incorporated?

Tam-Bran Pharmaceuticals Private Limited was incorporated on 30 September 1994.

Who are the current directors of Tam-Bran Pharmaceuticals Private Limited?

The current directors of Tam-Bran Pharmaceuticals Private Limited are

What is the primary industry of Tam-Bran Pharmaceuticals Private Limited?

The primary industry of Tam-Bran Pharmaceuticals Private Limited is Hospital And Medical Care.

Is Tam-Bran Pharmaceuticals Private Limited a listed company?

Tam-Bran Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Tam-Bran Pharmaceuticals Private Limited?

The authorized capital of Tam-Bran Pharmaceuticals Private Limited is ₹15.00 Cr, and the paid-up capital is ₹10.38 Cr.

What is the compliance status of Tam-Bran Pharmaceuticals Private Limited?

The compliance status of Tam-Bran Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available